Cargando…
Use of magnoflorine-phospholipid complex to permeate blood-brain barrier and treat depression in the CUMS animal model
To improve the liposolubility and blood-brain barrier permeability of magnoflorine, a new formulation of magnoflorine-phospholipid complex was prepared, characterized, and pharmacologically evaluated in the chronic unpredictable mild stress animal model. In this paper, the magnoflorine-phospholipid...
Autores principales: | Li, Bingjie, Han, Linmeng, Cao, Bingyan, Yang, Xiaoying, Zhu, Xuehui, Yang, Bing, Zhao, Haodong, Qiao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534223/ https://www.ncbi.nlm.nih.gov/pubmed/31104521 http://dx.doi.org/10.1080/10717544.2019.1616236 |
Ejemplares similares
-
Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts
por: Okon, Estera, et al.
Publicado: (2020) -
Magnoflorine Ameliorates Inflammation and Fibrosis in Rats With Diabetic Nephropathy by Mediating the Stability of Lysine-Specific Demethylase 3A
por: Chang, Liang, et al.
Publicado: (2020) -
The Cumming's Patent
Publicado: (1872) -
The Cummings' Patent
Publicado: (1872) -
The Cumming's Patent
por: Woodward, C. A., et al.
Publicado: (1872)